martes, 17 de noviembre de 2015

NGC Update Service: November 16, 2015 ► Health Awareness Topics - November 2015 || U.S. Food and Drug Administration (FDA) Advisory || Conference News

NGC Update Service: November 16, 2015



National Guideline Clearinghouse (NGC)

Conference News

  • The 8th Annual Conference on the Science of Dissemination and Implementation will take place from December 14-15, 2015 in Washington DC. The theme is "Optimizing Personal and Population Health." Visit theconference home page for more information.
  • The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, are available on the G-I-N Web site.

U.S. Food and Drug Administration (FDA) Advisory

  • November 6, 2015Plavix (clopidogrel): An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease. FDA evaluation of the Dual Antiplatelet Therapy (DAPT) trial and several other clinical trials also does not suggest that clopidogrel increases the risk of cancer or death from cancer.

Health Awareness Topics - November 2015

No hay comentarios:

Publicar un comentario